META’s Best Correction in a Long Time – A Prime Buying Opportuni
319
🔹 Current Price: $583.39 ✅ TP1: $620 – Short-Term Rebound to Mid-Channel Resistance ✅ TP2: $720 – Retesting Previous Highs ✅ TP3: $765+ – Analyst Average Target, Aligning with Recovery Patterns
🔥 Why Are We Bullish?
1️⃣ Analyst Ratings & Price Targets Strong Buy Consensus: Major institutions maintain bullish ratings on META. Average Price Target: $765 → +29% upside from current levels. Price Target Range: $580 (low) to $935 (high). JPMorgan Calls META a Top Pick: Meta and Spotify named as two of the best investment opportunities currently.
2️⃣ Market Correction Presents a Strong Entry Point
Biggest pullback since September 2023 – The last time META corrected 23% in two months, it fully recovered within two months and resumed its uptrend. META is now at major trendline support, historically a strong accumulation zone. RSI indicates potential reversal, aligning with previous rebounds.
3️⃣ AI Expansion & Business Growth Meta’s Llama AI Model Hits 1 Billion Downloads, reinforcing the company’s dominance in AI innovation. Heavy investments in AI & machine learning strengthen long-term growth prospects.
4️⃣ Strategic Growth & Revenue Expansion Strong Ad Revenue Growth: Despite market volatility, Meta’s ad business remains a cash machine. Metaverse & Reality Labs: Long-term investments positioning Meta as a leader in next-gen digital experiences. New Revenue Streams from AI & Cloud-Based Services: Expected to drive earnings in 2025 and beyond.
📌 Conclusion META’s 23% correction is presenting a rare discounted entry opportunity in an otherwise strong bullish trend. With AI growth, ad revenue expansion, and a rebound pattern that historically favors a recovery, META remains one of the best opportunities in the tech sector right now.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.